Diabetic Retinopathy Studies

Ongoing but not enrolling

  • Rise Ranibizumab Injection in patients with clinically significant macular edema with center involvement secondary to Diabetes.
  • VGFT-OD-1009 Intravitreal Injections of VEGF Trap-Eye in patients with Diabetic Macular Edema.
  • Quark QRK202– 2 part study
    • Part 1: Determines maximum tolerated dose of PF-04523655
    • Part 2: Study of PF-04523655 used alone and in combination with ranibizumab versus ranibizumab alone in patients with Diabetic Macular Edema.

Completed Studies

  • VGFT-OD-0706 Phase 2 study of intravitreal injections of VEGF Trap-Eye in patients with Diabetic Macular Edema.
This entry was posted in Uncategorized. Bookmark the permalink.